BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32541515)

  • 1. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
    Wu ZH; Zhou T; Sun HY
    Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
    Gao P; Lu W; Hu S; Zhao K
    Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
    Zhang JZ; Wu ZH; Cheng Q
    Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
    Wang Y; Zhao Q; Lan N; Wang S
    Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
    Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.
    Ge Y; He Z; Xiang Y; Wang D; Yang Y; Qiu J; Zhou Y
    Mol Biol Rep; 2019 Jun; 46(3):2829-2840. PubMed ID: 30830589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
    Tai J; Park J; Han M; Kim TH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
    Pan X; Liu JH
    Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
    Wang B; Wang W; Wang H; Liu W
    Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
    Jiang W; Cai R; Chen QQ
    Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration.
    Shen Y; Li M; Liu K; Xu X; Zhu S; Wang N; Guo W; Zhao Q; Lu P; Yu F; Xu X
    BMC Ophthalmol; 2020 Mar; 20(1):119. PubMed ID: 32209064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of pyroptosis-associated genes in nasopharyngeal carcinoma diagnosis and subtype classification.
    Wang Y; Zou Y; Chen X; Wang X; Zheng H; Ye Q
    J Gene Med; 2024 Jan; 26(1):e3653. PubMed ID: 38282154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.